Cidara Therapeutics - 48 Year Dividend Yield History | CDTX

Historical dividend payout and yield for Cidara Therapeutics (CDTX) since 1971. The current TTM dividend payout for Cidara Therapeutics (CDTX) as of February 19, 2019 is $0.00. The current dividend yield for Cidara Therapeutics as of February 19, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.070B $0.000B
Cidara Therapeutics, Inc. is a biotechnology company. The company is focused on the discovery, development and commercialization of novel anti-infectives. Its product pipeline includes CD101 IV, a long-acting echinocandin antifungal, CD101 topical and C001 which are in different clinical trial. The company developed its product using Cloudbreak(TM) immunotherapy platform. Cidara Therapeutics, Inc. is headquartered in San Diego, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $117.200B 13.07
Gilead Sciences (GILD) United States $87.436B 10.97
Bio-Techne Corp (TECH) United States $7.237B 48.76